Lunai Bioworks (LNAI) Research & Development (2015 - 2026)
Lunai Bioworks (LNAI) recorded quarterly Research & Development of $15946.0 in Q1 2026, down 65.24% quarter-over-quarter from $45872.0 in Q4 2025, and up 116.95% on a YoY basis from $7350.1 in Q1 2025.
Lunai Bioworks (LNAI) Research & Development (2015 - 2026) Analysis & Trends
Lunai Bioworks' Research & Development history runs 12 years deep, the most recent figure standing at $15946.0 for Q1 2026.
- In Q1 2026, Research & Development rose 116.95% year-over-year to $15946.0; the TTM figure through Mar 2026 stood at $166453.0 (down 81.33% YoY), while the FY2025 annual figure was $537428.0, down 80.16% from the prior year.
- Research & Development was $15946.0 for Q1 2026 at Lunai Bioworks, down from $45872.0 in the prior quarter.
- In the past five years, Research & Development ranged from a high of $2.6 million in Q3 2022 to a low of -$94073.0 in Q1 2025.
- Historically, Research & Development has averaged $616342.4 across 5 years, with a median of $390189.0 in 2024.
- The sharpest annual moves came in 2024 and 2025: Research & Development surged 354.62% in 2024, then plunged 108.65% in 2025.
- A 5-year view of Research & Development shows it stood at $325959.0 in 2022, then surged by 90.37% to $620521.0 in 2023, then sank by 74.04% to $161084.0 in 2024, then slumped by 71.52% to $45872.0 in 2025, then plunged by 65.24% to $15946.0 in 2026.
- The last three Research & Development figures came in at $15946.0 (Q1 2026), $45872.0 (Q4 2025), and $24407.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 4.32 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 15.66 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 626,092.00 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -101.30 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | -2.30 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 1.46 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 357,444.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 961.60 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -58.00 Mn |
| 10 | Lunai Bioworks | 95.85 Mn | 92.70 Mn | 20,942.00 | 15,946.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 15,946.00 |
| Dec 31, 2025 | 45,872.00 |
| Sep 30, 2025 | 24,407.00 |
| Jun 30, 2025 | 80,228.00 |
| Mar 31, 2025 | -94,073.00 |
| Dec 31, 2024 | 161,084.00 |
| Sep 30, 2024 | 390,189.00 |
| Jun 30, 2024 | 434,508.00 |
| Mar 31, 2024 | 1.09 Mn |
| Dec 31, 2023 | 620,521.00 |
| Sep 30, 2023 | 566,644.00 |
| Jun 30, 2023 | 994,726.00 |
| Mar 31, 2023 | 239,137.00 |
| Dec 31, 2022 | 325,959.00 |
| Sep 30, 2022 | 2.61 Mn |
| Jun 30, 2022 | 1.77 Mn |
| Mar 31, 2022 | 1.21 Mn |
| Dec 31, 2021 | 2.34 Mn |
| Sep 30, 2021 | 3.06 Mn |
| Jun 30, 2021 | 12.15 Mn |